Woodcock is ultimatly responsible for CDER. Division of Metabolic and Edocrine Products (DMEP) made a complete mess of Vascepa, Amarin and response to stakeholders.
Woodcock could have and should have ended this disaster October 2014....she needs to answer for this mistake.
FDA chose not to answer SPA 2015 60 day Budget order....they need to answer for this.
EPADI CP needs to be answered...after that, then I can point a finger.